Heart and brain: Do the risk factors have the same significance? Are the results of primary and secondary prevention trials comparable?;Le poids des facteurs de risque est-il le meme? Les resultats des etudes de prevention primaire et secondaire sont-ils comparables?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue SPEC. ISS. 5, 1998, Pages 59-63

  Castaigne, A ^a   Haziza, F ^a   Lopes Darmon, M E ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; PRIMARY PREVENTION; RISK BENEFIT ANALYSIS; RISK FACTOR; SECONDARY PREVENTION; SMOKING; ARTERIOSCLEROSIS; BLOOD; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; FIBRINOLYTIC THERAPY;

ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; CHOLESTEROL, LDL; CLINICAL TRIALS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; THROMBOLYTIC THERAPY;

EID: 0031722338     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mac Mahon S, Peto R, Cutler J et al. Blood pressure,stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990 ; 335 : 765-73.
2. Collins R, Peta R, Mac Mahon S et al. Blood pressure,stroke, and coronary heart disease. Part 2. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990 ; 335 : 827-38.
3. Insua JT, Sacks HS, Lau TS et al. Drug treatment of hypertension in the elderly : a meta-analysis. Ann Intern Med 1994 ; 121 : 355-62.
4. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med 1995 ; 333 : 1392-400.
5. Friedman GD, Dales LG, Ury HK. Mortality in middle-aged smokers and non-smokers. N Engl J Med 1979 ; 300 : 213-7.
6. Chen ZM, Xu Z, Collins R, Li WX, Peto R. Early health effects of the emerging tobacco epidemic in China. JAMA 1997 ; 278 : 1500-4.
7. Grundy SM. Statin and cholesterol lowering. Circulation 1998 ; 97 : 1436-9.
8. Prospective studies Collaboration. Cholesterol, diastolic blood pressure, and stroke : 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 1995 ; 346 : 1647-52.
9. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGCoA reductase inhibitors on stroke. A meta-analysis of randomized controlled trials. Ann Intern Med 1998 ; 128 : 89-95.
10. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke and total mortality : an overview of randomized trials. JAMA 1997 ; 278 : 313-21.
11. Antiplatelet trialists' collaboration. Collaborative overview of randomised trials of antiplatelet therapy. Br Med J 1994 ; 308 : 81-106.
12. Steering committee of physicians' health study research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989 ; 21 : 129-35.
13. The Medical research council's general practice research framework. Thrombosis prevention trial : randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998 ; 351 : 233-41.
14. ISIS-2 collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988 ; ii : 349-60.
15. Wradlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997 ; 350 : 607-14.
16. CAST collaborative group. CAST : randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997 ; 349 : 1641-9.